EGEBAK & NØRREVANG ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  13.8% 14.6% 22.4% 21.3% 18.1%  
Credit score (0-100)  16 13 3 4 8  
Credit rating  BB BB B B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  0.0 1,901 1,805 1,876 1,867  
EBITDA  339 33.6 79.5 97.8 178  
EBIT  293 -12.9 49.5 80.3 138  
Pre-tax profit (PTP)  253.2 -56.5 9.5 26.9 88.0  
Net earnings  253.2 -56.5 -59.3 26.9 88.0  
Pre-tax profit without non-rec. items  253 -56.5 9.5 26.9 88.0  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  186 186 226 236 210  
Shareholders equity total  44.4 -176 -235 -208 -120  
Interest-bearing liabilities  299 505 557 464 377  
Balance sheet total (assets)  1,051 878 892 919 921  

Net Debt  282 493 531 354 318  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 1,901 1,805 1,876 1,867  
Gross profit growth  -100.0% 0.0% -5.0% 3.9% -0.5%  
Employees  0 5 7 7 7  
Employee growth %  0.0% 0.0% 40.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,051 878 892 919 921  
Balance sheet change%  177.3% -16.5% 1.5% 3.1% 0.2%  
Added value  339.5 33.6 79.5 110.3 177.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  10 -46 10 -7 -66  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  5.0 -1.0 1.0 2.0 3.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% -0.7% 2.7% 4.3% 7.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  34.1% -1.2% 4.5% 7.3% 13.0%  
ROI %  95.5% -3.0% 9.3% 16.2% 33.4%  
ROE %  119.6% -12.2% -6.7% 3.0% 9.6%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  4.2% -4.4% -20.8% -18.5% -11.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  83.1% 1,467.1% 668.4% 362.0% 178.7%  
Gearing %  672.4% -287.3% -237.1% -223.2% -314.5%  
Net interest  0 0 0 0 0  
Financing costs %  14.0% 10.9% 7.5% 10.9% 12.5%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.6 0.6 0.6 0.5 0.5  
Current Ratio  0.8 0.8 0.8 0.7 0.8  
Cash and cash equivalent  16.4 11.6 25.8 110.1 59.4  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -221.3 -143.5 -182.4 -228.0 -182.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 7 11 16 25  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 7 11 14 25  
EBIT / employee  0 -3 7 11 20  
Net earnings / employee  0 -11 -8 4 13